Identification of Neoantigens and Construction of Immune Subtypes in Prostate Adenocarcinoma

Background: Messenger ribonucleic acid (mRNA) vaccine has been considered as a potential therapeutic strategy and the next research hotspot, but their efficacy against prostate adenocarcinoma (PRAD) remains undefined. This study aimed to find potential antigens of PRAD for mRNA vaccine development a...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yukui, Wang, Guixin, Chen, Yanzhuo, Zhang, Mingpeng, Gao, Wenlong, Shang, Zhiqun, Niu, Yuanjie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081437/
https://www.ncbi.nlm.nih.gov/pubmed/35547260
http://dx.doi.org/10.3389/fgene.2022.886983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081437/
https://www.ncbi.nlm.nih.gov/pubmed/35547260
http://dx.doi.org/10.3389/fgene.2022.886983

Ejemplares similares